Stay updated on Odevixibat for Biliary Atresia Post-Kasai Clinical Trial
Sign up to get notified when there's something new on the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page.

Latest updates to the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page
- Check6 days agoChange DetectedThe page now displays 'Last Update Posted (Estimated)' in the Study Record Dates and removes the previous 'Last Update Posted' label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedMetadata timestamps updated (e.g., 2025-12-29/30 and 'Last Update Posted') with no substantive changes to trial design or information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoChange DetectedSite locations were updated: new US state sites and Guangdong were added, while several existing locations were removed.SummaryDifference2%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedIPD sharing policy and data-transparency details were added, including that qualified researchers may request access to patient-level data and related study documents, with links to Ipsen's data-sharing resources and a stated data-access framework.SummaryDifference0.4%

- Check48 days agoChange DetectedThe site version history shows an addition of Revision: v3.3.2 and a deletion of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedRemoved the government funding status/operating status notice from the page. The page's core trial details and enrollment information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Odevixibat for Biliary Atresia Post-Kasai Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Odevixibat for Biliary Atresia Post-Kasai Clinical Trial page.